Your browser doesn't support javascript.
loading
A transit portal dosimetry method for respiratory gating quality assurance with a dynamic 3D printed tumor phantom.
Tan, Hong Qi; Koh, Calvin Wei Yang; Tan, Lloyd Kuan Rui; Lew, Kah Seng; Chua, Clifford Ghee Ann; Ang, Khong Wei; Lee, James Cheow Lei; Park, Sung Yong.
Afiliación
  • Tan HQ; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Koh CWY; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Tan LKR; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Lew KS; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Chua CGA; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Ang KW; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Lee JCL; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Park SY; Division of Physics and Applied Physics, Nanyang Technological University, Singapore, Singapore.
J Appl Clin Med Phys ; 23(5): e13560, 2022 May.
Article en En | MEDLINE | ID: mdl-35147283
ABSTRACT
BACKGROUNDS Respiratory gating is one of the motion management techniques that is used to deliver radiation dose to a tumor at a specific position under free breathing. However, due to the dynamic feedback process of this approach, regular equipment quality assurance (QA) and patient-specific QA checks need to be performed. This work proposes a new QA methodology using electronic portal imaging detector (EPID) to determine the target localization accuracy of phase gating.

METHODS:

QA tools comprising 3D printed spherical tumor phantoms, programmable stages, and an EPID detector are characterized and assembled. Algorithms for predicting portal dose (PD) through moving phantoms are developed and verified using gamma analysis for two spherical tumor phantoms (2 cm and 4 cm), two different 6 MV volumetric modulated arc therapy plans, and two different gating windows (30%-70% and 40%-60%). Comparison between the two gating windows is then performed using the Wilcoxon signed-rank test. An optimizer routine, which is used to determine the optimal window, based on maximal gamma passing rate (GPR), was applied to an actual breathing curve and breathing plan. This was done to ascertain if our method yielded a similar result with the actual gating window.

RESULTS:

High GPRs of more than 97% and 91% were observed when comparing the predicted PD with the measured PD in moving phantom at 2 mm/2% and 1 mm/1% levels, respectively. Analysis of gamma heatmaps shows an excellent agreement with the tumor phantom. The GPR of 40%-60% PD was significantly lower than that of the 30%-70% PD at the 1 mm/1% level (p = 0.0064). At the 2 mm/2% level, no significant differences were observed. The optimizer routine could accurately predict the center of the gating window to within a 10% range.

CONCLUSION:

We have successfully performed and verified a new method for QA with the use of a moving phantom with EPID for phase gating with real-time position management.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioterapia de Intensidad Modulada / Neoplasias Límite: Humans Idioma: En Revista: J Appl Clin Med Phys Asunto de la revista: BIOFISICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioterapia de Intensidad Modulada / Neoplasias Límite: Humans Idioma: En Revista: J Appl Clin Med Phys Asunto de la revista: BIOFISICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur